{"id":"https://openalex.org/W3036745944","doi":null,"title":"Dementia 2019: A review on advanced pharmacological therapies to treat Alzheimer\u2019s dementia- University Uttar Pradesh, India.","display_name":"Dementia 2019: A review on advanced pharmacological therapies to treat Alzheimer\u2019s dementia- University Uttar Pradesh, India.","publication_year":2020,"publication_date":"2020-01-01","ids":{"openalex":"https://openalex.org/W3036745944","mag":"3036745944"},"language":"en","primary_location":{"id":"mag:3036745944","doi":null,"is_oa":false,"landing_page_url":"https://www.iomcworld.org/articles/dementia-2019--a-review-on-advanced-pharmacological-therapies-to-treat-alzheimers-dementia-university-uttar-pradesh-indi.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"review","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051115318","display_name":"Surendra Adusumalli","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Surendra Adusumalli","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5051115318"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.00618673,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"2","issue":"2","first_page":"13","last_page":"15"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9824000000953674,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9824000000953674,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.00860000029206276,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.00839999970048666,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9959999918937683},{"id":"https://openalex.org/keywords/dementia","display_name":"dementia","score":0.5350000262260437},{"id":"https://openalex.org/keywords/acetylcholinesterase-inhibitors","display_name":"acetylcholinesterase inhibitors","score":0.9810000061988831},{"id":"https://openalex.org/keywords/memantine","display_name":"memantine","score":0.8510000109672546},{"id":"https://openalex.org/keywords/donepezil","display_name":"donepezil","score":0.7490000128746033},{"id":"https://openalex.org/keywords/rivastigmine","display_name":"rivastigmine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/galantamine","display_name":"galantamine","score":1.0},{"id":"https://openalex.org/keywords/disease-modifying-therapy","display_name":"disease-modifying therapy","score":0.8220000267028809},{"id":"https://openalex.org/keywords/amyloid-plaques","display_name":"amyloid plaques","score":0.875},{"id":"https://openalex.org/keywords/neurofibrillary-tangles","display_name":"neurofibrillary tangles","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cholinergic-side-effects","display_name":"cholinergic side effects","score":0.8820000290870667},{"id":"https://openalex.org/keywords/nmda-receptor-antagonist","display_name":"NMDA receptor antagonists","score":0.7850000262260437},{"id":"https://openalex.org/keywords/oxidative-stress","display_name":"oxidative stress","score":0.5870000123977661},{"id":"https://openalex.org/keywords/inflammation","display_name":"inflammation","score":0.4659999907016754},{"id":"https://openalex.org/keywords/cholesterol-metabolism","display_name":"cholesterol metabolism","score":0.6740000247955322}],"concepts":[{"id":"https://openalex.org/C2776332859","wikidata":"https://www.wikidata.org/wiki/Q411887","display_name":"Rivastigmine","level":5,"score":0.8193309307098389},{"id":"https://openalex.org/C2780904820","wikidata":"https://www.wikidata.org/wiki/Q415081","display_name":"Donepezil","level":4,"score":0.7754844427108765},{"id":"https://openalex.org/C2779056891","wikidata":"https://www.wikidata.org/wiki/Q412690","display_name":"Galantamine","level":5,"score":0.7647072076797485},{"id":"https://openalex.org/C2779484449","wikidata":"https://www.wikidata.org/wiki/Q412189","display_name":"Memantine","level":4,"score":0.7414175271987915},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.6738557815551758},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6064071655273438},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4958396852016449},{"id":"https://openalex.org/C502032728","wikidata":"https://www.wikidata.org/wiki/Q11081","display_name":"Alzheimer's disease","level":3,"score":0.4741251468658447},{"id":"https://openalex.org/C68026918","wikidata":"https://www.wikidata.org/wiki/Q1970256","display_name":"Senile plaques","level":4,"score":0.4591812789440155},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4169784188270569},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.3550816774368286},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.31007057428359985},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.2218109369277954}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:3036745944","doi":null,"is_oa":false,"landing_page_url":"https://www.iomcworld.org/articles/dementia-2019--a-review-on-advanced-pharmacological-therapies-to-treat-alzheimers-dementia-university-uttar-pradesh-indi.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1987204546","https://openalex.org/W2997944221","https://openalex.org/W3093231926","https://openalex.org/W2186563374","https://openalex.org/W2074717668","https://openalex.org/W1969793439","https://openalex.org/W2155039139","https://openalex.org/W4376871632","https://openalex.org/W2102188395","https://openalex.org/W2034347557"],"abstract_inverted_index":{"Alzheimer\u2019s":[0,25],"dementia":[1],"(AD)":[2],"is":[3,27,117],"increasingly":[4],"being":[5,206],"recognized":[6],"as":[7,139],"one":[8],"of":[9,32,71,102,126,135,151,170],"the":[10,30,61,69,100,133,149,152,159,164,168],"most":[11],"important":[12],"medical":[13],"and":[14,22,35,75,95,175,185,196],"social":[15],"problems":[16],"in":[17,20,45,208],"older":[18],"people":[19],"industrialized":[21],"non-industrialized":[23],"nations":[24],"disease":[26,153],"characterized":[28],"by":[29],"development":[31],"senile":[33],"plaques":[34,174],"neurofibrillary":[36,177],"tangles,":[37],"which":[38],"are":[39,68,77,142,204],"associated":[40],"with":[41,158],"neuronal":[42],"destruction,":[43],"particularly":[44],"cholinergic":[46,83],"neurons.":[47],"To":[48,147],"date,":[49],"only":[50],"symptomatic":[51,194],"treatments":[52,195],"exist":[53],"for":[54,99,112,163,201],"this":[55,189],"disease,":[56],"all":[57],"trying":[58],"to":[59,90,104,114,138,156],"counterbalance":[60],"neurotransmitter":[62],"acetyl":[63],"choline":[64],"degradation":[65],"within":[66],"synapses":[67],"mainstay":[70],"therapy.":[72],"Donepezil,":[73],"rivastigmine,":[74],"galantamine":[76],"safe":[78],"but":[79],"have":[80,96,155],"potentially":[81],"bothersome":[82],"side":[84],"effects.":[85],"Three":[86],"acetylcholinesterase":[87],"inhibitors":[88],"appear":[89],"be":[91],"effective,":[92],"currently":[93,205],"available":[94,111],"been":[97],"approved":[98],"treatment":[101],"mild":[103],"moderate":[105,113],"AD.":[106],"A":[107],"further":[108],"therapeutic":[109],"option":[110],"severe":[115],"AD":[116,202],"memantine,":[118],"an":[119],"N-methyl-D-aspartate":[120],"receptor":[121],"noncompetitive":[122],"antagonist.":[123],"Treatments":[124],"capable":[125],"stopping":[127],"or":[128],"at":[129],"least":[130],"effectively":[131],"modifying":[132],"course":[134],"AD,":[136],"referred":[137],"\u2018disease-modifying\u2019":[140],"drugs,":[141],"still":[143],"under":[144],"extensive":[145],"research.":[146],"block":[148],"progression":[150],"they":[154],"interfere":[157],"pathogenic":[160],"steps":[161],"responsible":[162],"clinical":[165],"symptoms,":[166],"including":[167],"deposition":[169],"extracellular":[171],"amyloid":[172],"\u03b2":[173],"intracellular":[176],"tangle":[178],"formation,":[179],"inflammation,":[180],"oxidative":[181],"damage,":[182],"iron":[183],"deregulation":[184],"cholesterol":[186],"metabolism":[187],"In":[188],"review":[190],"we":[191],"discuss":[192],"current":[193],"new":[197],"potential":[198],"disease-modifying":[199],"therapies":[200],"that":[203],"studied":[207],"phase":[209],"I\u2013III":[210],"trials.":[211]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2020-06-25T00:00:00"}